Tissue Repair Ltd
TRP
Rank in Stocks
#30556
Tissue Repair Ltd (TRP.AX) is an Australian clinical-stage biopharmaceutical... Tissue Repair Ltd (TRP.AX) is an Australian clinical-stage biopharmaceutical firm dedicated to pioneering advanced solutions for wound care. The company's primary focus lies in developing treatments for persistent chronic wounds and enhancing recovery following cosmetic procedures. Its product pipeline features TR-987 and a suite of innovative dressings and matrices, including the proprietary Glucoprime technology. These are specifically engineered to address challenging conditions such as chronic wounds, burns, and other complex dermal injuries. Additionally, TR Pro+ is being developed for post-procedure care after minimally invasive aesthetic treatments. Beyond these core programs, Tissue Repair is also exploring applications in animal health, novel bandage and scaffold technologies, and various other therapeutic areas. The company was founded in 2012 and operates from its headquarters in Sydney, Australia.
Share Price
$0.0899847
Last synced: 2026-11-10
Market Cap
$4.79M
Change (1 day)
0.00%
Change (1 year)
-54.58%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Tissue Repair Ltd (TRP)
Category
Healthcare
Operating Margin for Tissue Repair Ltd (TRP)
Operating Margin as of November 2026 TTM: -1,425.03%
According to Tissue Repair Ltd's latest financial reports, its current operating margin (TTM) is -1,425.03%. At the end of 2025 the company had an operating margin of -179.30%.
Operating Margin history for Tissue Repair Ltd from 2020 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -1,425.03% | 694.77% |
| 2025 | -179.30% | -95.81% |
| 2024 | -4,280.28% | -97.71% |
| 2023 | -186,616.71% | 7,492.71% |
| 2022 | -2,457.84% | 486.46% |
| 2021 | -419.10% | -99.85% |
| 2020 | -287,641.03% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| -195.39% | -99.86% |
US
|
|
| 33.87% | -100.02% |
US
|
|
| -116.04% | -99.92% |
US
|
|
| 25.57% | -100.02% |
AU
|
|
| 31.23% | -100.02% |
BE
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Tissue Repair Ltd's operating margin
What is Tissue Repair Ltd's operating margin?
Tissue Repair Ltd's operating margin is -1,425.03%, as of Nov 2026.
What was Tissue Repair Ltd's operating margin in 2025?
In 2025, Tissue Repair Ltd's operating margin was -179.30%, compared with -4,280.28% in 2024.
How has Tissue Repair Ltd's operating margin changed since 2020?
From 2020 to 2025, Tissue Repair Ltd's operating margin was highest in 2025 (-179.30%) and lowest in 2020 (-287,641.03%).
How does Tissue Repair Ltd's operating margin compare with similar companies?
Tissue Repair Ltd's operating margin (-1,425.03%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.